Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Sandoz Group Ag | LSE:0SAN | London | Ordinary Share | CH1243598427 | SANDOZ GROUP ORD SHS |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 25,025 | - |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Med, Dental, Hosp Eq-whsl | USD 9.65B | USD 77M | USD - | - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 10:36:47 | O | 80 | 39.33 | CHF |
| Date | Time | Source | Headline |
|---|---|---|---|
| 15/11/2024 | 06:00 | UKREG | Sandoz receives European Commission approval for Afqlir® (aflibercept),.. |
| 30/10/2024 | 06:00 | UKREG | Sandoz reports third-quarter and nine-month 2024 sales |
| 12/8/2024 | 05:00 | UKREG | Sandoz receives FDA approval for Enzeevu™ (aflibercept-abzv), further.. |
| 08/8/2024 | 05:00 | UKREG | Sandoz reports second-quarter sales and half-year 2024 results |
| 25/7/2024 | 05:00 | UKREG | Sandoz launches biosimilar Pyzchiva® (ustekinumab) across Europe, to treat.. |
| 01/7/2024 | 05:00 | UKREG | FDA approves biosimilar Pyzchiva® (ustekinumab-ttwe), to be commercialized.. |
| 22/5/2024 | 05:00 | UKREG | Sandoz receives European Commission approval for Wyost® and Jubbonti®, the.. |
| 07/5/2024 | 05:00 | UKREG | Sandoz reports first quarter 2024 sales |
| 30/4/2024 | 10:25 | UKREG | Shareholders approve all resolutions proposed by Board of Directors at.. |
| 30/4/2024 | 05:00 | UKREG | Sandoz reaches agreement with Amgen resolving all patent litigation related.. |
Sandoz (0SAN) Share Charts1 Year Sandoz Chart |
|
1 Month Sandoz Chart |
Intraday Sandoz Chart |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 10:36:48 | 39.33 | 80 | 0.00 | O |
| 10:35:48 | 39.33 | 14 | 0.00 | O |
| 10:34:43 | 39.32 | 60 | 0.00 | O |
| 10:05:00 | 39.45 | 11 | 0.00 | O |
| 10:04:59 | 39.45 | 2 | 0.00 | O |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
